2018 Webinar: Best Practices for Managing Cardiovascular Risk After Liver Transplantation
Recorded On: 10/31/2018
The overall objective of this activity is to address the epidemiology, risk factors and key challenges in the evaluation and management of cardiovascular disease risk factors in liver transplant recipients. In particular, we will discuss practical approaches and pharmacologic considerations in the prevention and management of hypertension, dyslipidemia and diabetes in liver transplant recipients. We will utilize a live webinar format that will be recorded for on demand viewing on LiverLearning®.
Manhal Izzy (Moderator)
Dr. Manhal Izzy is a transplant hepatologist and an assistant professor at Vanderbilt University School of Medicine. He is a member of the educational committee of the International Liver Transplantation Society (ILTS). His research focuses on cardiovascular outcomes in patients with liver disease.
Yogish Kudva is an adult Endocrinologist focused on clinical research involving patients with Type 1 diabetes. He has been involved in randomized, trials of T1D since 2000, Insulin pump trials since 2006 and artificial pancreas since 2009. His clinical and research work includes Beta Cell transplantation for Diabetes. His work is been funded by the NIH, JDRF and The Helmsley Trust.
Dr. Lisa VanWagner is an Assistant Professor of Medicine-GI & Hepatology and Preventive Medicine-Epidemiology at Northwestern University in Chicago, IL. Dr. VanWagner utilizes human population-based approaches, large electronic health record data analysis and health services research methods to define and characterize cardiovascular disease (risk prediction, prevention and treatment approaches in patients with chronic liver disease. Notably, she leads the multicenter Advancing Liver Therapeutic Approaches (ALTA) Consortium Study Group for the Management of Portal Hypertension and is the lead Principal investigator for ALTA TIPS, a U.S. based longitudinal observational study of patients who are undergoing transjugular intrahepatic portosystemic shunt (TIPS) placement. ALTA will create a database that will provide clinical parameters and outcomes of patients undergoing TIPS as part of their standard of care in hopes of answering key clinical questions about the utilization, outcomes and best practices surrounding TIPS as a therapeutic intervention for the complications of portal hypertension. She is an active member of AASLD, currently serving as a member of the Practice Guidelines Committee and is an Associate Editor for Liver Transplantation and Clinical Liver Disease.